By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mike Stratton has been named the new director of the Wellcome Trust Sanger Institute, where he has served as deputy director since 2007.

Stratton has been acting director of the institute's Board of Management since March, when Allan Bradley stepped down as director after 10 years at the institute's helm in order to found a startup company and focus on his research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.